Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 19/20 | 0.52 |
| ▸ | RET | P07949 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30669825 | 1.00 | KIT (0.52) | KITRET | |
| SCHEMBL30669810 | 0.89 | KIT (0.51) | KIT | |
| SCHEMBL29772725 | 0.89 | KIT (0.51) | KIT | |
| SCHEMBL29772784 | 0.86 | KIT (0.55) | KIT | |
| SCHEMBL24615215 | 0.86 | KIT (0.55) | KIT | |
| SCHEMBL27280129 | 0.86 | JAK1 (0.48) | KITRET | |
| SCHEMBL24615536 | 0.86 | JAK1 (0.48) | KITRET | |
| SCHEMBL30669778 | 0.86 | JAK1 (0.48) | KITRET | |
| SCHEMBL24615304 | 0.85 | KIT (0.49) | KIT | |
| SCHEMBL24615480 | 0.83 | KIT (0.52) | KIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547674-A1 | TYK2 INHIBITORS | Biogen MA Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-119731186-A | TYK2 inhibitors | 渤健马萨诸塞州股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024006493-A1 | TYK2 INHIBITORS | BIOGEN MA INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2024006493-A1 | TYK2 INHIBITORS | BIOGEN MA INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| EP-4274832-A1 | TYK2 INHIBITORS | Biogen MA Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| WO-2022150446-A1 | TYK2 INHIBITORS | BIOGEN MA INC. (US) | 2022-07-14 | — | — | WO | disclosed |